Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
Over time, consistent treatments help maintain steady energy, focus, and mood
Align your vial size with your dose so that you use the full vial within the 28-day window
Furthermore, peptides that promote tissue growth and repair include VEGF and FGF, and peptides that lower blood pressure and control cardiovascular function include ANP
US$ 23.30
US$ 29.35
US$ 29.81
US$ 20.33
US$ 25.41
US$ 22.32
US$ 23.36
US$ 28.34
